Orebro University
Also known as: Clinical Epidemiology and Biostatistics, School of medical Sciences, örebro University, Sweden | County Council of Orebro, | County Council of Orebro, University of Orebro, Sweden | Department of Anaesthesiology and Intensive Care, Örebro University Hospital | Department of Cardiology, Örebro Univerity Hospital, 701 85 Örebro, Sweden | Department of Cardiology, Orebro University Hospital, Sweden | Department of Cardiology, Respiratory medicine and Physiology, Örebro University Hospital | Dept. of Anesthesia and Intensive Care, Orebro University Hospital, Orebro, Sweden | Dept of Cardiothoracic Surgery and Anestesiology, University Hospital Orebro, Sweden | Dept. of Gynecological Surgery, Orebro University Hospital, Orebro, Sweden | Institute of Medical Sciences, Örebro University, 701 82, Örebro, Sweden | Örebro County Council | Örebro kommun | Örebro university | Örebro University | Ôrebro University Hospital | Orebro University Hospital, Orebro, Sweden | Orebro University Hospital, Sweden | Örebro University, Region Örebro County | Örebro University, Region Örebro Län | Örebro University, School of Medical Sciences, Sweden | Orebro University, Sweden | Örebro University, Sweden | Region Örebro County | Region Örebro County/Örebro University | Region Orebro lan | Region Örebro län | Region Örebro Län | Section for Hematology, Örebro University Hospital | Universitetssjukhuset Örebro | Universitetssjukhuset Örebro, ANIVA-kliniken | University Health Care Research Center, Faculty of Medicine and Health, Örebro University | University hospital in Örebro | University Hospital Orebro | University Hospital Orebro, Sweden | University of Orebro | UOS trattamenti integrati della carcinosi peritoneale avanzata -UOC Chirurgia del peritoneo e retroperitoneo - Fondazione Policlinico Universitario A. Gemelli IRCCS
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Sep 30, 2024
Timeline
1960s
- Jan 1, 1963
Orebro University— Founded
Drugs by trial phase (91 distinct, 81 trials)
Phase 4 (34 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (27 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Ascites
- Breast Neoplasms
- Carpal Tunnel Syndrome
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Colorectal Neoplasms
- Compulsive Personality Disorder
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Deglutition Disorders
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Disease
- Dyspepsia
- Encephalitis
- Encephalitis, Tick-Borne
- Esophageal Diseases
- Fibrosis
- Heart Failure
- Infarction
- Influenza, Human
- Ischemia
- Leiomyoma
- Liver Cirrhosis
- Lung Diseases
- Lung Diseases, Obstructive
- Major Depressive Disorder
- Mental Disorders
- Myalgia
- Myocardial Infarction
- Myocardial Ischemia
- Myofascial Pain Syndromes
- Myofibroma
- Neoplasms
- Obsessive-Compulsive Disorder
- Opioid-Related Disorders
- Pain
- Postoperative Complications
- Postoperative Pain
- Prostatic Neoplasms
- Psychotic Disorders
- Pulmonary Disease, Chronic Obstructive
- Rectal Neoplasms
- Schizophrenia
- Schizophrenia Spectrum and Other Psychotic Disorders
- Ulcer
- Uterine Neoplasms
- Vascular Diseases
Recent trials (50)
- NCT06488482CollaboratorPhase 3Sep 30, 2024
- NCT06419946CollaboratorPhase 3May 15, 2024
- NCT06223698Lead sponsorPhase 3May 2, 2024
- NCT06336317CollaboratorPhase 4Apr 24, 2024
- NCT06336317Lead sponsorPhase 4Apr 24, 2024
- NCT06336317OfficialPhase 4Apr 24, 2024
- NCT06319378CollaboratorPhase 2Apr 17, 2024
- NCT06142084Lead sponsorN/ADec 31, 2023
- NCT06045611Lead sponsorN/AOct 13, 2023
- NCT06081972Lead sponsorN/AOct 2, 2023
- NCT06081972Sponsor investigatorN/AOct 2, 2023
- NCT05852704Lead sponsorPhase 4Oct 2, 2023
- NCT06081972Reponsible party - principal investigatorN/AOct 2, 2023
- NCT05852704CollaboratorPhase 4Oct 2, 2023
- NCT05939076Lead sponsorPhase 3Aug 21, 2023
Details
- Founded
- Örebro, SE Jan 1, 1963
- Last known activity
- Sep 30, 2024